Mette Lund Pedersen

ORCID: 0009-0005-2290-3934 · 1 paper in corpus

article 2008

Lipid-based Formulations for Danazol Containing a Digestible Surfactant, Labrafil M2125CS: In Vivo Bioavailability and Dynamic In Vitro Lipolysis

·doi:10.1007/s11095-008-9641-0

PurposeTo evaluate the use of Labrafil M2125CS as a lipid vehicle for danazol. Further, the possibility of predicting the in vivo behavior with a dynamic in vitro lipolysis model was evaluated.MethodsDanazol (28 mg/kg) was administered oral…